Additionally, a range of sensitivity analyses (to be described below) were performed to explore dependence of ICERs on costs, efficacy of treatments and in particular network structure.
Altogether, we believe that Sesn's antioxidant roles, as well as other protective roles that will be described below, are functioning to attenuate age- or brain injury-induced neurodegenerative diseases.
What is described below is mainly based on this Appendix.
PAML (PAML and SLR are described below) was used to screen for codons with ω<1.0, estimated with a Bayes Empirical Bayes (BEB) probability of p>99%.
Ethical review for subsequent changes in the protocol, which are described below, were reviewed and approved.
(21) Aggregates of bone marrow plasma cells that were CD138 positive (the protocol for immunostaining is described below) were evaluated for LAT1 and CD98 expression in sequential slides.
The library preparation, Illumina sequencing, de novo assembly, read mapping and significance statistics, which are described below, were performed by BaseClear BV, the Netherlands (www.baseclear.com).
The cell lines above and primary human peripheral CD4+ T-cells (purification of these is described below) were all cultured in RPMI-1640 containing L-glutamine (Cambrex).
The electrophoresis mobility marker solution (10 μL; preparation is described below) was added to each sample in the 96-well plate and dried in a CVE.
The new A. gossypii strain (insect isolate 1), whose genome sequence is described below, was isolated from a large milkweed bug collected on oleander near Miami, Florida, in August 2005.
